Given the role of IL-22 in epithelial protection and tissue homeostasis, along with the growing recognition of the influence of the gut microbiota in IBD (16), we hypothesize that IL-22 signaling may drive hemopexin upregulation as a protective mechanism in colitis. The gene discussed is IL22; the disease is inflammatory bowel disease.